Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say 'There's No Stepping Back' From Legalization Wave
Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say 'There's No Stepping Back' From Legalization Wave
Flora Growth Corp. (NASDAQ:FLGC) has entered into a definitive agreement to acquire all of the issued and outstanding shares of Germany-based TruHC Pharma GmbH.
Flora Growth Corp.（納斯達克股票代碼：FLGC）已簽訂最終協議，收購總部位於德國的TruHC Pharma GmbH的所有已發行和流通股份。
The company's latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalizes cannabis by allowing adults over 18 to possess up to 25 grams of dried cannabis and grow three marijuana plants at home.
該公司爲進一步鞏固其全球足跡而採取的最新舉措是在德國一項新的大麻法於4月1日生效之後採取的，該法允許18歲以上的成年人擁有最多25克的幹大麻並在家中種植三種大麻植物，從而使大麻部分合法化。
Flora Growth, through its wholly-owned subsidiaries, has been active in Germany since 2017. Other companies, like Aurora Cannabis, Inc (NASDAQ:ACB) (TSX:ACB), Tilray Brands, Inc. (NASDAQ:TLRY) and Curaleaf Holdings Inc. (CSE:CURA) (OTCQX:CURLF) also ventured into the new market. Dr. Constantin von der Groeben, a managing director of Demecan – the only German vertically integrated medicinal cannabis company – told the crowd gathered at the Benzinga Cannabis Capital Conference on Tuesday that "There's no stepping back" from Germany's cannabis legalization.
自2017年以來，Flora Growth通過其全資子公司一直活躍在德國。其他公司，例如Aurora Cannabis公司（納斯達克股票代碼：ACB）（多倫多證券交易所股票代碼：ACB）、Tilray Brands, Inc.（納斯達克股票代碼：TLRY）和Curaleaf Holdings Inc.（CSE: CURA）（OTCQX: CURLF），也冒險進入新市場。德國唯一一家垂直整合的藥用大麻公司Demecan的董事總經理康斯坦丁·馮德格羅本博士週二對聚集在本辛加大麻資本會議上的人群說，德國的大麻合法化 “沒有退步的餘地”。
If you're interested in the latest developments in the industry, join us virtually at the ongoing Benzinga Cannabis Capital Conference in Florida. For existing subscribers, you can get direct access. New users, you can also get instant access here:
如果您對該行業的最新發展感興趣，請虛擬加入我們正在佛羅里達州舉行的Benzinga大麻資本會議。對於現有訂閱者，您可以直接訪問。新用戶，您還可以在此處即時訪問：
See also: Huge Benefits For Medical Marijuana Patients, Opportunities For Innovation & Research – Industry Vets Weigh In On Germany's Cannabis Reform
另見：醫用大麻患者的巨大好處，創新與研究的機會——行業資深人士權衡德國的大麻改革
Meanwhile, Flora Growth's acquisition deal combines the company's extensive global CPG and pharmaceutical distribution network with TruHC's deep global cannabis expertise, including an executive team that has been building medical and recreational cannabis companies across Germany, Canada, and the United States.
同時，Flora Growth的收購協議將該公司廣泛的全球CPG和藥品分銷網絡與TruHC深厚的全球大麻專業知識相結合，包括一個一直在德國、加拿大和美國建立醫療和休閒大麻公司的高管團隊。
As previously announced, Flora agreed to purchase TruHC Pharma GmbH in an all-stock deal in exchange for 2,770,562 of its common shares, valued at $6.4 million.
正如先前宣佈的那樣，弗洛拉同意以全股交易收購TruHC Pharma GmbH，以換取其價值640萬美元的2770,562股普通股。
The purchase price will be paid and satisfied by Flora in two closings. At the first closing, which is expected to occur by the end of April 2024, Flora will issue 2,135,199 of its shares, which is equal to 19.99% of the company's issued and outstanding common shares. On the second closing and upon shareholder approval of the issuance, Flora will issue 635,363 of its shares.
購買價格將由Flora在兩次收盤中支付並支付。在預計於2024年4月底舉行的首次收盤時，Flora將發行2,135,199股股票，相當於公司已發行和流通普通股的19.99％。在第二次收盤時，經股東批准發行，Flora將發行635,363股股票。
The acquisition capitalizes on TruHC's leading German cannabis platform, including:
此次收購利用了TruHC領先的德國大麻平台，包括：
- EU-GMP processing and production license
- GDP wholesale license for import/export
- EU-GMP-certified customizable modules with flexibility to incorporate various production/packaging processes and which enable license extension for future in-country cultivation and supply to cannabis dispensaries
- Narcotics license with EU-GMP-certified storage
- EU-GMP-certified laboratory for instant cannabis analysis
- EU-GMP 加工和生產許可證
- GDP 進口/出口批發許可證
- 經歐盟GMP認證的可定製模塊，可靈活地整合各種生產/包裝流程，並且可以延長未來國內種植和向大麻藥房供應的許可證
- 帶有歐盟 GMP 認證存儲空間的麻醉品許可證
- 歐盟 GMP 認證的即時大麻分析實驗室
"Now that Germany has rolled out its blueprint for recreational legalization, we intend to capitalize on the opportunity and work together to become the cannabis leader in the country," Hendrik Knopp, CEO of TruHC, said.
TruHC首席執行官亨德里克·諾普說：“既然德國已經推出了娛樂合法化藍圖，我們打算抓住機會，共同努力成爲該國的大麻領導者。”
Now read: This Cannabis Pioneer Is Ramping Up Its Presence In Germany As Weed Legalization Takes Effect
立即閱讀：隨着大麻合法化的生效，這位大麻先驅正在擴大在德國的影響力
FLGC Price Action
FLGC 價格走勢
Flora Growth's shares traded 2.75% lower at $1.77 per share at the time of writing on Wednesday mid-morning.
在週三上午撰寫本文時，Flora Growth的股價下跌2.75％，至每股1.77美元。
譯文內容由第三人軟體翻譯。